COMMUNIQUÉS West-GlobeNewswire

ERYTECH to Webcast Presentation at the Cowen and Company 38th Annual Healthcare Conference
13/03/2018
ERYTECH to Webcast Presentation at the Cowen and Company 38 th Annual Healthcare Conference Lyon (France), March 13, 2018 - ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical [...]
Dyadic International to Announce Year End 2017 Financial Results and Host Conference Call on Tuesday March 27, 2018
13/03/2018
JUPITER, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]
Teligent, Inc. to Present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday March 20, 2018
13/03/2018
BUENA, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 28 th Annual Healthcare Conference. The [...]
Auris Medical Provides Business Update
13/03/2018
Zug, Switzerland, March 13, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today provided an [...]
SELLAS Life Sciences to Present at the Oppenheimer 28th Annual Healthcare Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Coherus BioSciences Announces New Employment Inducement Grants
13/03/2018
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that effective March 12, 2018, the compensation committee of the company’s board of directors granted 2 [...]
Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer
13/03/2018
BURNABY, British Columbia, March 13, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical stage biopharmaceutical company, today announced that Dr. Ernesto Aycardi will join the company as its [...]
MediWound to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call on March 19 at 8:30 a.m. Eastern Time
13/03/2018
YAVNE, Israel, March 13, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Immunovaccine to Host Investor Event on April 10, 2018 in New York City
13/03/2018
HALIFAX, Nova Scotia, March 13, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced today that it will host an R&D Update and Investor Event for [...]
Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
13/03/2018
Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, covered in a separate release Management to host conference call at 4:30 PM EDT today CLEVELAND, March 13, 2018 [...]
AveXis Enters into Licensing Agreement with Genethon
13/03/2018
CHICAGO and ÉVRY, France , March 13, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ) and Genethon today announced they have entered into an exclusive, worldwide license agreement for in vivo gene therapy delivery [...]
GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex® (cannabidiol) Patents
13/03/2018
LONDON and CARLSBAD, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]
Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017
13/03/2018
Recruitment completed in European BP-004 registration trial of BPX-501 and rimiducid Positive BPX-501 interim results reported in AML and primary immunodeficiencies GoCAR-T candidate BPX-601 targeting PSCA in pancreatic [...]
Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results
13/03/2018
- VTL-308 Enrollment Nears Completion with 147 Subjects Enrolled as of March 12 - On Track for Release of Topline Results in Third Quarter of 2018 SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. ( [...]
Supernus Announces Proposed Private Offering of $350 Million of Convertible Senior Notes
13/03/2018
ROCKVILLE, Md., March 13, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ) (the “Company”), a specialty pharmaceutical company focused on developing and commercializing products for the treatment [...]
Sientra Reports Fourth Quarter and Full Year 2017 Financial Results
13/03/2018
Remains on Track for Full and Final FDA Approval for U.S. Manufactured Implants Received ISO 13485 Certification for Breast Implants and Tissue Expanders Advanced miraDry Integration and Optimization Strategy SANTA [...]
How to Control Oily Skin - 10 Do’s and Don’ts from Dermatologists; American Academy of Dermatology
13/03/2018
ROSEMONT, Ill., March 13, 2018 (GLOBE NEWSWIRE) -- Although oily skin can clog pores and lead to increased acne breakouts, dermatologists from the American Academy of Dermatology say oily skin also has many benefits. [...]
Crinetics Pharmaceuticals Completes $63.5 Million Series B Financing
13/03/2018
SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced it has completed a Series [...]
Novozymes A/S’ annual shareholders’ meeting 2018
13/03/2018
Please read the full announcement in the attached PDF 2018_08_Novozymes_annual_shareholders_meeting_EN

Pages